# SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease

> **NCT00820365** · PHASE2 · COMPLETED · sponsor: **4SC AG** · enrollment: 34 (actual)

## Conditions studied

- Inflammatory Bowel Disease (IBD)

## Interventions

- **DRUG:** SC12267 (4SC-101)

## Key facts

- **NCT ID:** NCT00820365
- **Lead sponsor:** 4SC AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-10
- **Final completion:** 2011-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2011-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820365, "SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00820365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*